Morgan Stanley Launches Next Level Fund in Partnership with Hearst, Microsoft and Walmart to Invest in Diverse Start-Ups

Fund to Invest in Women and Multicultural Founded Early-Stage Companies Fund builds on expertise from the…

Continue Reading

Immunicom Presentation Defines Breakthrough Subtractive Therapy’s Role in “New Era” Cancer Care at LSI’s Annual Emerging MedTech Summit

Immunicom CEO predicting cancer treatment standards will evolve with better quality-of-life and efficacy outcomes by employing…

Continue Reading

Pershing Square Tontine Holdings, Ltd. Provides Summary of the Transactions Slide Presentation

NEW YORK–(BUSINESS WIRE)–Pershing Square Tontine Holdings, Ltd. (NYSE:PSTH) today released a presentation on its website that…

Continue Reading

PSTH to Acquire 10% of the Ordinary Shares of UMG from Vivendi S.E. for Approximately $4 billion, Representing an Enterprise Value of €35 Billion

UMG Shares to be Distributed to PSTH Shareholders Later this Year PSTH to Remain a Publicly…

Continue Reading

ROSEN, A TOP RANKED LAW FIRM, Encourages Ocugen, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline – OCGN

NEW YORK–(BUSINESS WIRE)–WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of…

Continue Reading

DEADLINE TOMORROW: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES–(BUSINESS WIRE)–$EBS #EBS–The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of…

Continue Reading

DEADLINE TOMORROW: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES–(BUSINESS WIRE)–$ACAD #ACAD–The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of…

Continue Reading

ADC Therapeutics Presents Updated ZYNLONTA™ (loncastuximab tesirine-lpyl) Clinical Data at 16th Annual International Conference on Malignant Lymphoma

LOTIS-2 updated results demonstrate durable responses of ZYNLONTA™ with median duration of response of 13.4 months…

Continue Reading

Insights on the Healthcare Discount Plan Global Market to 2026 – by Service, Deployment Model, End-user and Geography – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Healthcare Discount Plan Market (2021-2026) by Service, Deployment Model, End user, Geography, Competitive…

Continue Reading

Moderna Reaffirms Commitment to Job Creation in Massachusetts

Company recently announced expansion of the Moderna Technology Center in Norwood, MA Company has nearly doubled…

Continue Reading